2006
DOI: 10.14227/dt130106p20
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Assessment of Different Dissolution Apparatus for Floating Drug Delivery Systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 10 publications
(11 reference statements)
0
11
0
Order By: Relevance
“…Previous comparative studies of different dissolution apparatus (i.e. USP and non-USP) focused mainly on tablets (24,(29)(30)(31) and capsules (25,31,32). Only a few studies have dealt with active pharmaceutical ingredients (API) in the powdered form (23,33,34), and with limited scope, involving less than three apparatus.…”
Section: Introductionmentioning
confidence: 99%
“…Previous comparative studies of different dissolution apparatus (i.e. USP and non-USP) focused mainly on tablets (24,(29)(30)(31) and capsules (25,31,32). Only a few studies have dealt with active pharmaceutical ingredients (API) in the powdered form (23,33,34), and with limited scope, involving less than three apparatus.…”
Section: Introductionmentioning
confidence: 99%
“…Literature reports indicate that the modified dissolution apparatus can more closely simulate most of the in vivo conditions[1314]. …”
mentioning
confidence: 99%
“…However, this may be associated with a number of difficulties such as adherence of the tested product to the paddle shaft or sample withdrawal aid (pipette), incomplete exposure to the dissolution medium, and failure to predict in vivo performance (26). To overcome such problems, some researchers have alternatively used certain modifications to the paddle method (27,28), modified the dissolution apparatus (26,29,30), or used the FTC (USP Apparatus 4) (31).…”
Section: Pharmacokinetic Rationalementioning
confidence: 99%